Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


19.07.2021

1 AIDS
1 Ann Intern Med
1 Ann N Y Acad Sci
10 BMJ
5 Clin Infect Dis
1 J Gen Virol
1 J Immunol
2 JAMA
1 Lancet
3 MMWR Morb Mortal Wkly Rep
11 N Engl J Med
2 Nat Immunol
4 Nat Med
4 Pediatr Infect Dis J
7 PLoS One
2 Science
11 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. RUDDY JA, Boyarsky BJ, Bailey JR, Karaba AH, et al
    Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96349.
    PubMed         Abstract available


    Ann Intern Med

  2. KLOMPAS M, Pearson M, Morris C
    The Case for Mandating COVID-19 Vaccines for Health Care Workers.
    Ann Intern Med. 2021 Jul 13. doi: 10.7326/M21-2366.
    PubMed        


    Ann N Y Acad Sci

  3. SUMMAN A, Nandi A, Deo S, Laxminarayan R, et al
    Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush.
    Ann N Y Acad Sci. 2021 Jul 15. doi: 10.1111/nyas.14657.
    PubMed         Abstract available


    BMJ

  4. CROZIER A, Dunning J, Rajan S, Semple MG, et al
    Could expanding the covid-19 case definition improve the UK's pandemic response?
    BMJ. 2021;374:n1625.
    PubMed        

  5. TANNE JH
    Covid-19: Biden renews vaccines push as cases and deaths rise among unvaccinated people.
    BMJ. 2021;374:n1742.
    PubMed        

  6. WILKINSON D, Finlay I, Pollard AJ, Forsberg L, et al
    Should we delay covid-19 vaccination in children?
    BMJ. 2021;374:n1687.
    PubMed        

  7. TORJESEN I
    Covid-19: Free rapid testing may end once most adults are fully vaccinated.
    BMJ. 2021;374:n1760.
    PubMed        

  8. DYER O
    Covid-19: Turkmenistan becomes first country to make vaccination mandatory for all adults.
    BMJ. 2021;374:n1766.
    PubMed        

  9. TINARI S, Riva C
    Donuts, drugs, booze, and guns: what governments are offering people to take covid-19 vaccines.
    BMJ. 2021;374:n1737.
    PubMed        

  10. DYER O
    Covid-19: Regulators warn that rare Guillain-Barre cases may link to J&J and AstraZeneca vaccines.
    BMJ. 2021;374:n1786.
    PubMed        

  11. WISE J
    Covid-19: France and Greece make vaccination mandatory for healthcare workers.
    BMJ. 2021;374:n1797.
    PubMed        

  12. O'DOWD A
    Covid-19 vaccination: GPs ruled out of booster campaign at practice level.
    BMJ. 2021;374:n1811.
    PubMed        

  13. TORJESEN I
    Covid-19: Vaccine centres operating at 30% capacity as young people stay away.
    BMJ. 2021;374:n1808.
    PubMed        


    Clin Infect Dis

  14. SKOWRONSKI DM, Setayeshgar S, Zou M, Prystajecky N, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada.
    Clin Infect Dis. 2021 Jul 9. pii: 6318435. doi: 10.1093.
    PubMed         Abstract available

  15. DAWOOD FS, Naleway AL, Flannery B, Levine MZ, et al
    Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
    Clin Infect Dis. 2021 Jul 10. pii: 6318730. doi: 10.1093.
    PubMed         Abstract available

  16. IJAZ S, Derrick J, Shute J, Ireland G, et al
    Mother To Infant Transmission Of Hepatitis B Virus In The Face Of Neonatal Immunisation Is Not Necessarily Primary Vaccine Failure.
    Clin Infect Dis. 2021 Jul 12. pii: 6319332. doi: 10.1093.
    PubMed         Abstract available

  17. LIN DY, Gu Y, Zeng D, Janes HE, et al
    Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Jul 14. pii: 6321290. doi: 10.1093.
    PubMed         Abstract available

  18. TOTA JE, Giuliano AR, Goldstone SE, Dubin B, et al
    Anogenital HPV Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial.
    Clin Infect Dis. 2021 Jul 15. pii: 6321740. doi: 10.1093.
    PubMed         Abstract available


    J Gen Virol

  19. RESLAN L, Mishra N, Finianos M, Zakka K, et al
    The origins of G12P[6] rotavirus strains detected in Lebanon.
    J Gen Virol. 2021;102.
    PubMed         Abstract available


    J Immunol

  20. BARBER-AXTHELM IM, Kelly HG, Esterbauer R, Wragg KM, et al
    Coformulation with Tattoo Ink for Immunological Assessment of Vaccine Immunogenicity in the Draining Lymph Node.
    J Immunol. 2021 Jul 9. pii: jimmunol.2001299. doi: 10.4049/jimmunol.2001299.
    PubMed         Abstract available


    JAMA

  21. ABBASI J
    Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.
    PubMed        

  22. GOLDSHTEIN I, Nevo D, Steinberg DM, Rotem RS, et al
    Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    JAMA. 2021 Jul 12. pii: 2782047. doi: 10.1001/jama.2021.11035.
    PubMed         Abstract available


    Lancet

  23. TANRIOVER MD, Doganay HL, Akova M, Guner HR, et al
    Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
    Lancet. 2021 Jul 8. pii: S0140-6736(21)01429.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  24. SCHERER AM, Gedlinske AM, Parker AM, Gidengil CA, et al
    Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents - United States, April 15-23, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:997-1003.
    PubMed         Abstract available

  25. WONG CA, Dowler S, Moore AF, Sosne EF, et al
    COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:991-996.
    PubMed         Abstract available

  26. PINGALI C, Meghani M, Razzaghi H, Lamias MJ, et al
    COVID-19 Vaccination Coverage Among Insured Persons Aged >/=16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:985-990.
    PubMed         Abstract available


    N Engl J Med

  27. WANG GL, Wang ZY, Duan LJ, Meng QC, et al
    Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103022.
    PubMed        

  28. SHEN X, Tang H, Pajon R, Smith G, et al
    Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2103740.
    PubMed        

  29. ANICHINI G, Terrosi C, Gandolfo C, Gori Savellini G, et al
    SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2103825.
    PubMed        

  30. LAI KY, Au SY, Fong KM
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021;385:e11.
    PubMed        

  31. CHOI PY
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021;385:e11.
    PubMed        

  32. EICHINGER S, Warkentin TE, Greinacher A
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021;385:e11.
    PubMed        

  33. ROPPER AH, Klein JP
    Cerebral Venous Thrombosis.
    N Engl J Med. 2021;385:59-64.
    PubMed        

  34. BAROUCH DH, Stephenson KE, Sadoff J, Yu J, et al
    Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2108829.
    PubMed        

  35. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
    N Engl J Med. 2021;385:e18.
    PubMed        

  36. NORMARK J, Vikstrom L, Gwon YD, Persson IL, et al
    Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2110716.
    PubMed        

  37. MOON S, Alonso Ruiz A, Vieira M
    Averting Future Vaccine Injustice.
    N Engl J Med. 2021;385:193-196.
    PubMed        


    Nat Immunol

  38. CUPOVIC J, Ring SS, Onder L, Colston JM, et al
    Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8(+) T cells.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00969.
    PubMed         Abstract available

  39. DAI L, Xu K, Li J, Huang Q, et al
    Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00966.
    PubMed         Abstract available


    Nat Med

  40. CHEMAITELLY H, Yassine HM, Benslimane FM, Al Khatib HA, et al
    mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar.
    Nat Med. 2021 Jul 9. pii: 10.1038/s41591-021-01446.
    PubMed         Abstract available

  41. LOUBET P, Wittkop L, Tartour E, Parfait B, et al
    A French cohort for assessing COVID-19 vaccine responses in specific populations.
    Nat Med. 2021 Jul 12. pii: 10.1038/s41591-021-01435.
    PubMed        

  42. BARROS-MARTINS J, Hammerschmidt SI, Cossmann A, Odak I, et al
    Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.
    Nat Med. 2021 Jul 14. pii: 10.1038/s41591-021-01449.
    PubMed         Abstract available

  43. O'LEARY K
    Another COVID-19 vaccine to boost rollout.
    Nat Med. 2021 Jul 15. pii: 10.1038/d41591-021-00045.
    PubMed        


    Pediatr Infect Dis J

  44. BLUMENFELD O, Lawrence G, Shulman LM, Laron Z, et al
    Use of the Whole Country Insulin Consumption Data in Israel to Determine the Prevalence of Type 1 Diabetes in Children <5 Years of Age Before and During Rotavirus Vaccination.
    Pediatr Infect Dis J. 2021;40:771-773.
    PubMed         Abstract available

  45. HASSAN J, Toh TH, Sivapunniam SK, Hasim R, et al
    Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9-13 Years of Age in Malaysia: A Phase IIIb, Randomized, Open-label Study.
    Pediatr Infect Dis J. 2021;40:774-781.
    PubMed         Abstract available

  46. WIERINGA JW, van Beek RHT, Rovekamp LW, Driessen GJA, et al
    Response to Vaccination in Infants Exposed to Antitumor Necrosis Factor Alpha In Utero.
    Pediatr Infect Dis J. 2021 Jul 13. pii: 00006454-900000000-95765.
    PubMed         Abstract available

  47. SARMIENTO CLEMENTE A, Amerson-Brown MH, Foster CE
    An Adolescent With Neurobrucellosis Caused by Brucella abortus Cattle Vaccine Strain RB51.
    Pediatr Infect Dis J. 2021 Jul 13. pii: 00006454-900000000-95761.
    PubMed         Abstract available


    PLoS One

  48. KOLLI SK, Salman AM, Ramesar J, Chevalley-Maurel S, et al
    Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.
    PLoS One. 2021;16:e0254498.
    PubMed         Abstract available

  49. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    PubMed         Abstract available

  50. YASSI A, Grant JM, Lockhart K, Barker S, et al
    Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
    PLoS One. 2021;16:e0254920.
    PubMed         Abstract available

  51. STODDARD M, Sarkar S, Yuan L, Nolan RP, et al
    Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2.
    PLoS One. 2021;16:e0254734.
    PubMed         Abstract available

  52. LU M, Ishwaran H
    Cure and death play a role in understanding dynamics for COVID-19: Data-driven competing risk compartmental models, with and without vaccination.
    PLoS One. 2021;16:e0254397.
    PubMed         Abstract available

  53. ALAGOZ O, Sethi AK, Patterson BW, Churpek M, et al
    The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.
    PLoS One. 2021;16:e0254456.
    PubMed         Abstract available

  54. AHMED MH, Kanfe SG, Jarso MH
    Intention to receive vaccine against COVID-19 and associated factors among health professionals working at public hospitals in resource limited settings.
    PLoS One. 2021;16:e0254391.
    PubMed         Abstract available


    Science

  55. COHEN J
    Can immune responses predict which vaccines work best?
    Science. 2021;373:142-143.
    PubMed        

  56. WADMAN M
    Journal retracts paper claiming COVID-19 vaccines kill.
    Science. 2021;373:147.
    PubMed        


    Vaccine

  57. AT THOBARI J, Damayanti W, Haposan JH, Nirwati H, et al
    Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial.
    Vaccine. 2021 Jul 6. pii: S0264-410X(21)00832.
    PubMed         Abstract available

  58. DING Y, Luo L, Luo Y, Zhao D, et al
    A novel combined vaccine against classical swine fever and porcine epidemic diarrhea viruses elicits a significant Th2-favored humoral response in mice.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00846.
    PubMed         Abstract available

  59. CLARKE M, Goodchild LM, Evans S, Giles LC, et al
    Body mass index and vaccine responses following influenza vaccination during pregnancy.
    Vaccine. 2021 Jul 12. pii: S0264-410X(21)00826.
    PubMed         Abstract available

  60. GOMEZ M, McCollum J, Wang H, Bachchhav S, et al
    Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery.
    Vaccine. 2021 Jul 10. pii: S0264-410X(21)00861.
    PubMed         Abstract available

  61. GOOCH KE, Smith TRF, Salguero FJ, Fotheringham SA, et al
    One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00807.
    PubMed         Abstract available

  62. GUKTUR RE, Nep EI, Asala O, Olorunfemi PO, et al
    Carboxymethylated and acetylated xerogel derivatives of Plectranthus esculentus starch protect Newcastle disease vaccines against cold chain failure.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00812.
    PubMed         Abstract available

  63. ZHANG T, Zhang J, Shao X, Feng S, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00836.
    PubMed         Abstract available

  64. FONGWEN N, Delrieu I, Ham LH, Gubler DJ, et al
    Implementation strategies for the first licensed dengue vaccine: A meeting report.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00845.
    PubMed         Abstract available

  65. TERNA RICHARD M, Taiwo L, Jean Baptiste AE, Bawa S, et al
    Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Vaccine. 2021 Jul 8. pii: S0264-410X(21)00831.
    PubMed         Abstract available

  66. HINES AM, Murphy N, Mullin C, Barillas J, et al
    Henoch-Schonlein purpura presenting post COVID-19 vaccination.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00841.
    PubMed        

  67. MATEO-URDIALES A, Del Manso M, Andrianou X, Spuri M, et al
    Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00862.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: